Monocyte enriched apheresis for preparation of dendritic cells (DC) to be used in cellular therapy
- 31 October 2005
- journal article
- Published by Elsevier BV in Transfusion and Apheresis Science
- Vol. 33 (2), 165-173
- https://doi.org/10.1016/j.transci.2005.04.009
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Development of a technology platform for large-scale clinical grade production of DCCytotherapy, 2004
- Improving the efficiency of PBPC collection by pre-apheresis peripheral blood and mid-apheresis product measurements of CD34 cellsCytotherapy, 2004
- Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanomaCancer Immunology, Immunotherapy, 2004
- Comparison of two apheresis systems for the collection of CD14+ cells intended to be used in dendritic cell cultureTransfusion, 2003
- Monocyte enrichment from leukapharesis products for the generation of DCs by plastic adherence, or by positive or negative selectionCytotherapy, 2003
- Effects of leukapheresis protocol, cell processing and cryopreservation on the generation of monocyte-derived DC for immune therapyCytotherapy, 2003
- Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapyCytotherapy, 2001
- Kinetic studies during peripheral blood stem cell collection show CD34+ cell recruitment intra‐apheresisJournal of Clinical Apheresis, 2001
- Generation of anti‐idiotype immune responses following vaccination with idiotype‐protein pulsed dendritic cells in myelomaBritish Journal of Haematology, 1999
- PBSC harvests individually optimized by using pre-collection CD34+ values and on-line flow cytometric analysis of the mononuclear cell enrichmentCytotherapy, 1999